RNAC
Cartesian Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.46 / 10
Underperform
Technical metrics reveal a weak structure scoring only 1.46/10. Dominant bearish signals include MACD Death Cross, Long Upper Shadow, and Long Lower Shadow, indicating a high probability of further decline.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate34.00%
Hist. Signals50
Avg Return-0.38%
Score1/10
Win Rate34.00%
Hist. Signals50
Avg Return-0.38%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-0.63%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-0.63%
Long Lower Shadow
Score2.39/10
Win Rate45.24%
Hist. Signals42
Avg Return0.20%
Score2.39/10
Win Rate45.24%
Hist. Signals42
Avg Return0.20%
Long Upper Shadow
Score1/10
Win Rate34.00%
Hist. Signals50
Avg Return-0.38%
Score1/10
Win Rate34.00%
Hist. Signals50
Avg Return-0.38%
Long Lower Shadow
Score2.39/10
Win Rate45.24%
Hist. Signals42
Avg Return0.20%
Score2.39/10
Win Rate45.24%
Hist. Signals42
Avg Return0.20%
MACD Death Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-0.63%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-0.63%
Technical Analysis of RNAC?
- RNAC presents a Underperform setup with a Technical Score of 1.46/10. Key technical indicators highlight an RSI of 39.23 and a MACD of -0.21, with the trend anchored by the 50-Day SMA at 7.29. Traders should monitor key support at 6.06 and resistance at 6.71.
